Similar articles

• A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.

  Fujisaki S, Takashita E, Yokoyama M, Taniwaki T, Xu H, Kishida N, Sato H, Tashiro M, Imai M, Odagiri T. Fujisaki S, et al. Biochem Biophys Res Commun. 2012 Dec 7;429(1-2):51-6. doi: 10.1016/j.bbrc.2012.10.095. Epub 2012 Nov 3. Biochem Biophys Res Commun. 2012. PMID: 23131559
• Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.

  Harada N, Shibata W, Koh H, Takashita E, Fujisaki S, Okamura H, Nanno S, Yamada K, Nakamae H, Hino M, Kakeya H. Harada N, et al. BMC Infect Dis. 2020 Jul 6;20(1):478. doi: 10.1186/s12879-020-05205-1. BMC Infect Dis. 2020. PMID: 32631240 Free PMC article.
• [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].

  Ferraris O, Escuret V, Bouscambert-Duchamp M, Lina B, Morfin F. Ferraris O, et al. Pathol Biol (Paris). 2010 Apr;58(2):e69-78. doi: 10.1016/j.patbio.2010.01.011. Epub 2010 Mar 19. Pathol Biol (Paris). 2010. PMID: 20303677 Review. French.
• Neuraminidase inhibitor resistance in influenza viruses.

  Reece PA. Reece PA. J Med Virol. 2007 Oct;79(10):1577-86. doi: 10.1002/jmv.20951. J Med Virol. 2007. PMID: 17705169 Review.
• Drugs: Lines of defence.

  Palmer R. Palmer R. Nature. 2011 Dec 7;480(7376):S9-10. doi: 10.1038/480S9a. Nature. 2011. PMID: 22158299 No abstract available.